BridgeMD
New treatment option for Amyloidosis
Official title Prevalence and Significance of ATTR Aortic Valve Amyloidosis in Degenerative Aortic Stenosis
ClinicalTrials.gov ID: NCT04636684
What this study is testing
- What it's testing
- Cardiac amyloidosis is a restrictive cardiomyopathy with a potentially severe prognosis that can be life-threatening. It is linked in the vast majority of cases to a light chain deposition of immunoglobulin or transthyretin.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Patient over 18 years old
- Degenerative aortic stenosis
- Aortic valve replacement surgery
- Signature of the informed consent form
You likely can't join if
- Non-degenerative aortic stenosis: bicuspid, rheumatic disease, aortic regurgitation
- Persons under a system of legal protection for adults (guardianship, curatorship, etc.)
- Pregnant women
The study team makes the final eligibility decision.
Where it's taking place
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toulouse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.